Healios
Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.
1
Funding Rounds
$9.9m
Money raised
Overview
Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.
- Websites:
- Business model: B2B
- Headquarters: Tokyo
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Healios has raised a total of $9.9m in funding over 1 rounds.
Key Insights:
- Healios May 2021 Series A Funding Round: $9.9m
Healios May 2021 Series A Funding Round
$9.9m
Industries
Healios is active in the following industries: